Online access to provider guided wellness programs
REJUVONIX
Checking session…
Menu

Protocol education · Cognitive / neurological

DSIP

Sleep-related peptide education included for catalog completeness and provider-led evidence review.

Compounded medication vial
01

Understand

What this entry means.

This page provides structured education and a path to independent clinical review. Inclusion in the master protocol library is not a prescription, endorsement, guarantee of availability or statement that the protocol is appropriate for a particular person.

02

Discuss

What a provider may need to review.

  • Sleep symptoms and underlying causes
  • Evidence quality and regulatory status
  • Evidence-based sleep evaluation and treatment alternatives
03

Verify

Regulatory and clinical context.

This educational listing does not establish clinical availability or an FDA-approved indication.

Connected pathway

From discovery to documented next steps.

Rejuvonix keeps the protocol pathway connected without bypassing provider review.

  1. 01Learn

    Review the protocol education and its regulatory context.

  2. 02Assess

    Complete the appropriate Rejuvonix assessment when you are ready.

  3. 03Provider review

    An independent licensed provider determines whether any treatment is appropriate.

  4. 04Source & document

    If treatment is prescribed, pharmacy/source and applicable quality documentation remain connected to the pathway.

Quality & documentation

Documentation follows the exact formulation and batch.

COAs shown here are the supplied documents for the named formulation and lot. Original certificate files are preserved unchanged. FDA-approved finished products use official prescribing documentation; compounded formulations may also have their own batch-specific COAs.

COA available

DSIP

Batch-by-batch COAs

Review the certificate package for each listed batch.

Some batches include more than one companion record. Part 1 and Part 2 links stay grouped under the same lot so the complete documentation set remains intact.

01

DSIP batch

DSIP 1 mg/mL solution

Lot / Batch
0024-062526-1
Laboratory
Miraxis Labs
Document date
2026-07-03

Next step

Clinical decisions stay with licensed providers.

Completing an assessment does not guarantee treatment or a prescription.

Continue to performance assessment